FREMONT, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- In a move that underscores its dedication to shaping the future of cell analysis, Cytek Biosciences, Inc. (CTKB) (Nasdaq: CTKB) today announced the ...
FREMONT, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Continuing its commitment to advancing cell analysis, Cytek Biosciences, Inc. (Nasdaq: CTKB) is showcasing its patented Full Spectrum Profiling™ ...
FREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research and diagnostics driving the need for deeper, faster cellular insights, spectral flow cytometry leader Cytek Biosciences, Inc.
Cytek Biosciences, Inc. has announced that it will release its financial results for the first quarter of 2025 on May 8, 2025, after the market closes. Following the release, the company's management ...
Cytek Biosciences, Inc. announced that it will release its second quarter 2025 financial results on August 6, 2025, after market close. The company will host a conference call and webcast at 1:30 p.m.
“Our third quarter results are encouraging and demonstrate the strength of our established brand and technology and our market leadership position,” said Wenbin Jiang, CEO of Cytek Biosciences. “As we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback